Data supports safety of Dynavax hepatitis B vaccine: FDA panel
(Reuters) - Available data supports the safety of Dynavax Technologies Corp's experimental hepatitis B vaccine when administered to adults, a panel of expert advisers to the U.S. Food and Drug Administration said on Friday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Food and Drug Administration (FDA) | Health | Hepatitis | Hepatitis B | Hepatitis Vaccine | Vaccines